When we say someone has a big heart, they are kind and generous, love to give and help others and bring joy to all they ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Radiation-induced cardiomyopathy has become a significant clinical challenge with the increased use of ...

Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complications due to its invasive nature. Researchers have now found a way to ...

BridgeBio’s ATTR cardiomyopathy drug, Attruby, achieved promising sales numbers in the weeks after its FDA approval.

Prescription totals for Attruby, which is locked in a closely watched commercial battle with Pfizer’s tafamidis, have more ...

BridgeBio beat investor expectations with 1,028 unique prescriptions for ATTR-CM therapy Attruby, setting the company up to beat a 2025 sales consensus of $86 million.

A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another ...

Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complication due to its invasive nature. Researchers have now found a way to ...

Medically reviewed by Smita Patel, DO Duchenne muscular dystrophy (DMD) is a rare neurological condition that causes severe muscle weakness and intellectual disability. DMD is an inherited (passed ...

Gregg Stone cast doubt on its reliability in trials, while David Cohen said QoL matters to patients and should be measured.

Take the time to understand more about your big heart. It’s Heart Health Month! And the Hypertrophic Cardiomyopathy Association is empowering patients and advancing research for a brighter ...

A research team co-led by scientists at the University of Arizona College of Medicine—Tucson found that an osteoporosis drug ...